Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessPrimary research

ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target

Sandra-Nadia Ngwabyt Bikeye1 email, Carole Colin2 email, Yannick Marie1 email, Raphaël Vampouille4 email, Philippe Ravassard4 email, Audrey Rousseau5 email, Blandine Boisselier1 email, Ahmed Idbaih1,3 email, Charles Félix Calvo1 email, Pascal Leuraud6 email, Myriam Lassalle6 email, Soufiane El Hallani1 email, Jean-Yves Delattre1,3 email and Marc Sanson1,3 email

UMR975 INSERM-UPMC, GH Pitié- Salpêtrière, Paris

UMR911-CRO2, Faculté de Médecine Timone, Université de la Méditerranée, Marseille

Service de Neurologie Mazarin, GH Pitié- Salpêtrière, APHP, Paris

Biotechnology & Biotherapy laboratory, Centre de Recherche de l'Institut du Cerveau et de la Moelle, CNRS UMR9225, INSERM UMRS 975 Université Pierre et Marie Curie, Hôpital de la Salpêtrière, Paris

Service de Neuropathologie Raymond Escourolle, GH Pitié- Salpêtrière, Paris

XenTech, Evry, France

author email corresponding author email

Cancer Cell International 2010, 10:1doi:10.1186/1475-2867-10-1

Published: 11 January 2010

Abstract

Background

ASPM (Abnormal Spindle-like Microcephaly associated) over-expression was recently implicated in the development of malignant gliomas.

Results

To better characterize the involvement of ASPM in gliomas, we investigated the mRNA expression in 175 samples, including 8 WHO Grade II, 75 WHO Grade III and 92 WHO Grade IV tumors. Aspm expression was strongly correlated with tumor grade and increased at recurrence when compared to the initial lesion, whatever the initial grade of the primary tumor. ASPM expression also increased over serial passages in gliomaspheres in vitro and in mouse xenografts in vivo. Lentivirus-mediated shRNA silencing of ASPM resulted in dramatic proliferation arrest and cell death in two different gliomasphere models.

Conclusion

These data suggest that ASPM is involved in the malignant progression of gliomas, possibly through expansion of a cancer stem cell compartment, and is an attractive therapeutic target in glioblastoma multiforme.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.